Global Preeclampsia Diagnostics Market Size study & Forecast, by Test Type (Blood Tests, Urine Analysis), by Product (Instruments, Consumables), by End-User (Hospitals, Specialty Clinics, Diagnostic Centers & Others) & Regional Analysis, 2022-2029

Description

List of Tables

Global Preeclampsia Diagnostics Market is valued at approximately USD 1.03 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 2.2% over the forecast period 2022-2029. Preeclampsia, commonly referred to as toxaemia, is a progressively growing condition marked by raised blood pressure and high protein in pregnant women's urine. One of the hypertensive disorders of pregnancy that accelerates maternal and perinatal morbidity and mortality rates among women in industrialized and developing countries is this one. The Preeclampsia Diagnostics market is expanding because of factors such as increasing incidence of Preeclampsia among female population, and growing focus on the development of innovative preeclampsia diagnostic products.

Pregnant women globally are likely to have a rising demand for early preeclampsia diagnosis, which is anticipated to fuel the expansion of the global preeclampsia diagnostics market over the forecast period. For instance, the Preeclampsia Foundation predicts that over 10 million women worldwide suffer from preeclampsia each year and that preeclampsia contributes to over 2.5 million preterm births. Furthermore, Preeclampsia affected at least 1 in 7 deliveries during this time, according to the Centers for Disease Control and Prevention, and its prevalence among hospitalisations for childbirth increased from around 13% in 2017 to 16% in 2019. Another important component driving space increase is increase in funding for diagnosis and treatment of Preeclampsia. For instance, on February 2, 2022, the Preeclampsia Foundation and Preeclampsia Foundation Canada, its Canadian affiliate, would each award one medical research Vision Grant, up to US$ 20,000, for the study of preeclampsia and related hypertensive diseases of pregnancy. However, less awareness about preeclampsia may halt market growth.

The key regions considered for the Global Preeclampsia Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue. The market expansion in this region is attributed to the increasing adoption of technologically improved goods, rising patient and healthcare provider awareness of the seriousness of the disease, and considerable healthcare spending. Additionally, the industry is projected to rise as more cutting-edge preeclampsia diagnostics products are introduced. Whereas Europe is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising target populations. Further, a sizable patient base with hypertensive problems during pregnancy is expected to fuel market growth. Additionally, a rise in government healthcare organizations' approvals of the diagnosis of hypertensive problems in pregnancy may promote market expansion in Europe.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd
PerkinElmer Inc.
DRG instruments GMBH
Thermo Fisher Scientific Inc.
Diabetomics, Inc.
Metabolomic Diagnostics Ltd.
Sera Prognostics
Siemens Healthineers AG
Danaher Corporation (Beckman Coulter, Inc.)
Bio-Rad Laboratories, Inc.

Recent Developments in the Market:

In June 2021, In India, LifeCell Diagnostics introduced a thorough preeclampsia screening programme. The sophisticated screening finds sFLT-1 (soluble FMS-like tyrosine kinase-1), a biomarker that allows for reliable diagnosis even in the third trimester and allows for illness prediction.
In July 2019, The Preeclampsia Foundation and Predictive Laboratories, Inc. formed a research partnership. The objective of this collaboration is to create a tailored test for the early identification of risk in disease-affected women.

Global Preeclampsia Diagnostics Market Report Scope:

Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Test Type, Product, End-User, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Test Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Test Type:

Blood Tests
Urine Analysis

By Product:

Instruments
Consumables

By End-User:

Hospitals
Specialty Clinics
Diagnostic Centers
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Preeclampsia Diagnostics Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Preeclampsia Diagnostics Market, by Test Type, 2019-2029 (USD Billion)
- 1.2.3. Preeclampsia Diagnostics Market, by Product, 2019-2029 (USD Billion)
- 1.2.4. Preeclampsia Diagnostics Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Preeclampsia Diagnostics Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Preeclampsia Diagnostics Market Dynamics

3.1. Preeclampsia Diagnostics Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of Preeclampsia among female population
  - 3.1.1.2. Growing Focus on the Development of Innovative Preeclampsia Diagnostic Products
- 3.1.2. Market Challenges
  - 3.1.2.1. Less Awareness about Preeclampsia
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increase in Funding for Diagnosis and Treatment of Preeclampsia

Chapter 4. Global Preeclampsia Diagnostics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Preeclampsia Diagnostics Market, by Test Type

6.1. Market Snapshot
6.2. Global Preeclampsia Diagnostics Market by Test Type, Performance - Potential Analysis
6.3. Global Preeclampsia Diagnostics Market Estimates & Forecasts by Test Type 2019-2029 (USD Billion)
6.4. Preeclampsia Diagnostics Market, Sub Segment Analysis
- 6.4.1. Blood Tests
- 6.4.2. Urine Analysis

Chapter 7. Global Preeclampsia Diagnostics Market, by Product

7.1. Market Snapshot
7.2. Global Preeclampsia Diagnostics Market by Product, Performance - Potential Analysis
7.3. Global Preeclampsia Diagnostics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
7.4. Preeclampsia Diagnostics Market, Sub Segment Analysis
- 7.4.1. Instruments
- 7.4.2. Consumables

Chapter 8. Global Preeclampsia Diagnostics Market, by End-User

8.1. Market Snapshot
8.2. Global Preeclampsia Diagnostics Market by End-User, Performance - Potential Analysis
8.3. Global Preeclampsia Diagnostics Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Preeclampsia Diagnostics Market, Sub Segment Analysis
- 8.4.1. Hospitals
- 8.4.2. Specialty Clinics
- 8.4.3. Diagnostic Centers
- 8.4.4. Others

Chapter 9. Global Preeclampsia Diagnostics Market, Regional Analysis

9.1. Preeclampsia Diagnostics Market, Regional Market Snapshot
9.2. North America Preeclampsia Diagnostics Market
- 9.2.1. U.S. Preeclampsia Diagnostics Market
  - 9.2.1.1. Test Type breakdown estimates & forecasts, 2019-2029
  - 9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
  - 9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Preeclampsia Diagnostics Market
9.3. Europe Preeclampsia Diagnostics Market Snapshot
- 9.3.1. U.K. Preeclampsia Diagnostics Market
- 9.3.2. Germany Preeclampsia Diagnostics Market
- 9.3.3. France Preeclampsia Diagnostics Market
- 9.3.4. Spain Preeclampsia Diagnostics Market
- 9.3.5. Italy Preeclampsia Diagnostics Market
- 9.3.6. Rest of Europe Preeclampsia Diagnostics Market
9.4. Asia-Pacific Preeclampsia Diagnostics Market Snapshot
- 9.4.1. China Preeclampsia Diagnostics Market
- 9.4.2. India Preeclampsia Diagnostics Market
- 9.4.3. Japan Preeclampsia Diagnostics Market
- 9.4.4. Australia Preeclampsia Diagnostics Market
- 9.4.5. South Korea Preeclampsia Diagnostics Market
- 9.4.6. Rest of Asia Pacific Preeclampsia Diagnostics Market
9.5. Latin America Preeclampsia Diagnostics Market Snapshot
- 9.5.1. Brazil Preeclampsia Diagnostics Market
- 9.5.2. Mexico Preeclampsia Diagnostics Market
- 9.5.3. Rest of Latin America Preeclampsia Diagnostics Market
9.6. Rest of The World Preeclampsia Diagnostics Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies
10.2. Company Profiles
- 10.2.1. F. Hoffmann-La Roche Ltd
  - 10.2.1.1. Key Information
  - 10.2.1.2. Overview
  - 10.2.1.3. Financial (Subject to Data Availability)
  - 10.2.1.4. Product Summary
  - 10.2.1.5. Recent Developments
- 10.2.2. PerkinElmer Inc.
- 10.2.3. DRG instruments GMBH
- 10.2.4. Thermo Fisher Scientific Inc.
- 10.2.5. Diabetomics, Inc.
- 10.2.6. Metabolomic Diagnostics Ltd.
- 10.2.7. Sera Prognostics
- 10.2.8. Siemens Healthineers AG
- 10.2.9. Danaher Corporation (Beckman Coulter, Inc.)
- 10.2.10. Bio-Rad Laboratories, Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Preeclampsia Diagnostics Market, report scope
TABLE 2. Global Preeclampsia Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Preeclampsia Diagnostics Market estimates & forecasts by Test Type 2019-2029 (USD Billion)
TABLE 4. Global Preeclampsia Diagnostics Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 5. Global Preeclampsia Diagnostics Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Preeclampsia Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Preeclampsia Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Preeclampsia Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Preeclampsia Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Preeclampsia Diagnostics Market
TABLE 71. List of primary sources, used in the study of global Preeclampsia Diagnostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Preeclampsia Diagnostics Market, research methodology
FIG 2. Global Preeclampsia Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Preeclampsia Diagnostics Market, key trends 2021
FIG 5. Global Preeclampsia Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Preeclampsia Diagnostics Market, porters 5 force model
FIG 7. Global Preeclampsia Diagnostics Market, pest analysis
FIG 8. Global Preeclampsia Diagnostics Market, value chain analysis
FIG 9. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Preeclampsia Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Preeclampsia Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Preeclampsia Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Preeclampsia Diagnostics Market, company Market share analysis (2021)